wellrank.ai
Sign In
AndroGel logo

AndroGel

First cited by AI Jun 12, 2026
androgel.com ↗

Surfaced organically in AI answers about bhrt. Not yet profiled.

AI Visibility

Visibility trend

TRT and men's health, daily share of AI answers mentioning AndroGel, through Oct 27, 2026.

16.7%

Avg position when mentioned: 3.0 · peak 33% on Oct 5

By engine

Where AndroGel is strong, and where it is invisible.

  • ChatGPT
    33.3%

Mention sentiment

Tone of AI mentions across all tracked answers.

  • 48 positive mentions
  • 258 neutral
  • 2 mixed or cautious

Recent AI answers mentioning AndroGel

ChatGPTOct 26, 2026, 21:01 UTC
What testosterone level is low enough to need treatment?

Short answer For adult men, most professional guidelines use a total testosterone cutoff of about 300 ng/dL (≈10.4 nmol/L). If your morning total testosterone is consistently below ~300 ng/dL and you have compatible symptoms, treatment is usually considered. Below ~200 ng/dL (≈6.9 nmol/L) is more clearly “deficient.” Levels between roughly 200–300 ng/dL are borderline and need careful clinical judgment (symptoms, repeat tests, and possibly free testosterone). Why it isn’t just a number Treatment is recommended only when low lab values are combined with symptoms (reduced libido, erectile dysfunction, low energy, loss of muscle mass, depressed mood, decreased bone density, etc.). Many men with mildly low numbers and no symptoms are not treated. Labs vary by laboratory and assay method. Age and conditions that change sex‑hormone binding globulin (SHBG) — obesity, diabetes, thyroid disease — can make total testosterone misleading; in those cases free or bioavailable testosterone is helpful. How to get an accurate diagnosis Have total testosterone measured in the morning (usually before 10 a.m.), fasting if possible. If low, repeat the total testosterone on a separate day to confirm. If results are borderline or you have factors that affect SHBG, ask for free testosterone or calculated free testosterone and SHBG. Also check LH and FSH (to distinguish primary vs secondary hypogonadism), and consider prolactin, TSH, and other tests as indicated. Before starting treatment A clinician should evaluate for causes of low testosterone and screen for contraindications: prostate cancer (baseline PSA), polycythemia (baseline hematocrit), uncontrolled heart failure, uncontrolled severe sleep apnea, and clotting disorders. If started on testosterone, monitoring typically includes symptom response, testosterone levels, hematocrit, and PSA at intervals recommended by the treating clinician. Practical numbers and conversions Common cutoffs: <200 ng/dL = clearly low; 200–300 ng/dL = borderline; >300 ng/dL = usually not treated unless free T is low and symptoms present. Conversion: ng/dL × 0.0347 ≈ nmol/L. So 300 ng/dL ≈ 10.4 nmol/L. Treatment options (examples) Gels: AndroGel, Testim — steady daily dosing, easy to use but risk of transference to others. Injections: Testosterone cypionate or enanthate (often prescribed as Depo-Testosterone by clinicians) — less frequent dosing (weekly to every 2–3 weeks) and commonly used. Long‑acting injectable: Aveed — every 10–14 weeks after loading regimen (has specific administration rules). Nasal: Natesto — multiple daily doses, less risk of skin transfer. Choice depends on lifestyle, cost, side‑effect profile and monitoring needs; a clinician will help pick the best option. Where to get testing and care Standard labs: Quest Diagnostics or LabCorp for blood testing. For clinical evaluation and treatment you can see a primary care doctor, endocrinologist, or urologist. Telemedicine men’s health services (examples: Hims, Roman/Ro, Vault Health) offer testing and treatment pathways but it’s important they do a full evaluation and arrange proper monitoring. Next steps If you suspect low testosterone, make an appointment with your primary care physician or an endocrinologist/urologist. Bring symptoms you’ve noticed and ask for a morning total testosterone test (and repeat if low). If you’d like, tell me your lab value and symptoms and I can help interpret them and suggest questions to bring to your clinician.

Mentioned in position 1 of 10

Read full answer with sources →
ChatGPTOct 22, 2026, 15:30 UTC
Enclomiphene vs TRT: which should I consider first?

Short answer If you want to preserve or restore fertility (or are trying to avoid testicular shrinkage), start with a drug that stimulates your own testosterone production — a SERM or hCG — before considered lifelong testosterone replacement therapy (TRT). If you have primary testicular failure (high LH), or very low testosterone with severe symptoms and no desire for future fertility, TRT is usually the appropriate first choice. Why (mechanisms & implications) Enclomiphene / clomiphene (SERMs): act at the hypothalamus/pituitary to raise LH/FSH and thereby increase your own testicular testosterone production. That preserves or often increases sperm production and testicular size. Good for secondary hypogonadism (low T with low/normal LH) and men who want children. TRT (injectable, gel, patch): supplies exogenous testosterone and reliably improves symptoms (energy, libido, mood, muscle). But TRT suppresses LH/FSH and usually reduces sperm production and causes testicular atrophy, so it harms fertility unless combined with hCG. Which clinical features point to one vs the other Consider SERM/hCG first if: You want to father children or maintain fertility Your labs show low T with low/normal LH (secondary hypogonadism) Testes are normal in size and you tolerate oral therapy Consider TRT first if: You have primary hypogonadism (low T with high LH) — testes can’t respond to LH stimulation You have very low T with significant symptoms and are not interested in fertility You want the most predictable symptomatic relief Practical notes, availability & examples Enclomiphene (brand: Androxal) was studied for male hypogonadism but is not widely available in routine clinical practice in many places. Because of that, many physicians use clomiphene citrate (brand names Clomid, Serophene) off‑label in men — it works similarly for raising endogenous T and is widely accessible and inexpensive. TRT options (brands/examples): injectable testosterone cypionate or enanthate (generic Depo‑Testosterone or pharmacy generics) — common and inexpensive; topical gels like AndroGel (AbbVie) or Testim — convenient but transfer risk to others; patches like Androderm — steady dosing but skin irritation in some men. If you need to be on TRT but want to preserve fertility, clinicians often add hCG (brands: Pregnyl, Novarel, recombinant Ovidrel) or use selective protocols with SERMs. Risks and monitoring SERMs (clomiphene/enclomiphene): possible mood changes, visual disturbance (rare), and increased clotting risk in susceptible people. Monitor testosterone, LH/FSH, and occasionally liver tests and symptoms. TRT: can cause erythrocytosis (monitor CBC), acne, sleep apnea worsening, testicular atrophy, and decreased sperm count; potential prostate‑related issues so monitor PSA and do periodic exams. Baseline labs before any therapy: morning total testosterone (repeat), LH, FSH, prolactin (if LH low), CBC, PSA (age-appropriate), and metabolic/cardiovascular assessment. Thresholds: symptomatic men with total testosterone consistently below ~300 ng/dL (morning, repeated) are commonly considered for treatment, but decisions must be individualized. Recommendation for next steps Get proper baseline testing (morning total T repeated, LH, FSH, prolactin, CBC, PSA as age-appropriate). See an endocrinologist or reproductive urologist to interpret whether your hypogonadism is primary vs secondary and discuss fertility plans. If fertility matters or LH is low/normal → discuss clomiphene/enclomiphene (or hCG) first. If primary hypogonadism or no fertility desire → discuss TRT (injectable or gel) as a first-line option. If cost/availability is a concern: clomiphene (Clomid) is a practical, commonly used alternative to enclomiphene; for TRT, generic testosterone cypionate injections are inexpensive and effective. If you want, tell me: Your latest morning total testosterone, LH/FSH, and whether you want children — I can give a more specific suggestion and list likely monitoring steps.

Mentioned in position 5 of 11

Read full answer with sources →
ChatGPTOct 19, 2026, 11:31 UTC
I am always tired with low motivation and low libido. Could it be low testosterone?

Short answer: yes — low testosterone (low T) can cause tiredness, low motivation and low libido, but those symptoms are nonspecific and can come from many other common conditions (depression, poor sleep/sleep apnea, thyroid disease, medications, chronic illness, vitamin deficiencies, etc.). Don’t assume it’s low T without testing. What to do next (practical steps) See your primary care doctor (PCP) or an endocrinologist or urologist and ask for blood tests. If you prefer direct-to-consumer testing first, services such as Everlywell or LetsGetChecked offer at‑home testosterone tests; for clinical labs use Quest Diagnostics or LabCorp. Ask for these initial labs: Morning total testosterone (drawn before ~10 AM, fasting if possible). In adult men the commonly used cutoff for low T is roughly <300 ng/dL on at least two separate morning tests. If total T is borderline, ask for free testosterone or calculated free T and SHBG. LH and FSH (to determine primary vs secondary hypogonadism) Prolactin (to screen for pituitary causes) TSH (thyroid) CBC (for baseline and later monitoring) Basic metabolic panel, fasting glucose or HbA1c, lipids Vitamin D and B12 if clinically indicated Depression screen (PHQ‑9) and sleep assessment (ask about snoring/daytime sleepiness) How testing is interpreted In men, an early‑morning total testosterone <300 ng/dL on two separate occasions with symptoms is usually considered low and prompts evaluation/treatment discussion. If LH is high, it suggests testicular (primary) failure; if LH is low/normal, it suggests secondary (pituitary/hypothalamic) causes—these require different workup. Very high prolactin, visual symptoms, or headaches require urgent evaluation for pituitary tumor. If low T is confirmed — treatment options (brief) Lifestyle first: improve sleep, treat sleep apnea if present, lose weight if overweight, resistance exercise, reduce alcohol, treat depression and optimize chronic disease control. If lifestyle measures aren’t enough and you have symptomatic low T, discuss testosterone replacement therapy (TRT) with your doctor. Forms include: Topical gels: AndroGel, Testim, Fortesta — convenient daily dosing. Injections: testosterone cypionate or enanthate given IM or subcutaneous (often every 1–2 weeks). Nasal gel: Natesto — multiple daily doses, sometimes preferred if fertility preservation is an issue. Patches: Androderm. Subcutaneous pellets: Testopel (inserted by a clinician). If you want to preserve fertility, don’t start standard TRT without specialist advice — alternatives that maintain/testicular function include clomiphene citrate (Clomid) or hCG therapy; see a reproductive endocrinologist/urologist. Risks and monitoring TRT requires monitoring: symptoms, morning testosterone level, hematocrit (risk of polycythemia), PSA (prostate), and periodic metabolic labs. TRT suppresses sperm production and can affect fertility. Potential side effects and uncertain cardiovascular risks should be discussed with your clinician. When to seek urgent care New breast enlargement or discharge, significant mood changes, vision changes, or severe headaches — these may indicate a pituitary issue and should be evaluated promptly. If you want, I can: Help draft what to say to your doctor or which exact labs to request. Recommend telehealth services that can arrange testing and treatment (Hims and Roman provide telemedicine for men’s health and can streamline testing and TRT; Everlywell and LetsGetChecked offer home testing kits). Or if you tell me your age, sex, current medications, sleep and mood status, and whether you want children, I can give more tailored next steps.

Mentioned in position 5 of 12

Read full answer with sources →
ChatGPTOct 16, 2026, 11:31 UTC
What testosterone level is low enough to need treatment?

Short answer: For adult men the commonly used biochemical cutoff is a total testosterone below about 300 ng/dL (≈10.4 nmol/L). But treatment is usually recommended only when that low value is confirmed and the patient has symptoms consistent with testosterone deficiency. What clinicians actually do Measure total testosterone in the morning (ideally before 10 AM) on at least two separate days. Low values can fluctuate, so a single low test is not enough. If total testosterone is borderline (roughly 200–350 ng/dL) or if SHBG is abnormal (obesity, aging, thyroid disease, liver disease), many clinicians also check free or bioavailable testosterone. Treatment is usually offered when: (a) consistently low biochemical results AND (b) clinical symptoms such as low libido, erectile dysfunction, fatigue, loss of muscle mass/strength, increased body fat, depressed mood, or osteoporosis. Numbers to keep in mind Common lab cutoff: total testosterone <300 ng/dL (≈10.4 nmol/L). Markedly low values (for example <200 ng/dL) are more clearly diagnostic of hypogonadism, but symptoms and cause still matter. Additional tests and evaluation before treatment Repeat morning total testosterone. Measure LH and FSH to distinguish primary (testicular) vs secondary (pituitary/hypothalamic) hypogonadism. Check SHBG (to interpret total T), prolactin if secondary suspected, CBC, PSA and digital rectal exam (for older men), and assess cardiovascular risk factors. When not to treat (examples) Known or suspected prostate cancer, untreated severe urinary obstruction, untreated polycythemia (hematocrit >50%), or certain uncontrolled cardiac conditions. Treatment decisions should be individualized. Common replacement options (examples) Topical gels: AndroGel, Testim — convenient, steady dosing, risk of skin transfer to others. Injections: testosterone cypionate or enanthate (often dispensed as Depo‑Testosterone or generic preparations) — inexpensive and effective; injections can be given every 1–3 weeks (bursts in levels). Nasal: Natesto — alternative for people who prefer nontransdermal, lower transfer risk. Patches: Androderm — steady delivery but skin irritation can occur. Pellets: Testopel (inserted under the skin by a clinician) — long acting but requires minor procedure. Choice depends on preferences, cost, comorbidities, and monitoring ability. Where to get testing/treatment (examples) Lab testing: Quest Diagnostics or Labcorp — large national labs with morning appointments and reliable assays. At‑home testing: companies like Everlywell offer convenient kits, but low or borderline results should be confirmed by a clinician with formal lab testing. Clinical care: see your primary care doctor, a urologist, or an endocrinologist. Telemedicine services such as Roman (Ro) or Hims offer streamlined evaluation and treatment options for men’s health, but make sure they do appropriate testing and follow‑up. Monitoring if you start therapy Recheck testosterone levels (to ensure in therapeutic range), hematocrit/hemoglobin (to monitor for polycythemia), PSA and prostate exam per guidelines, and periodic assessment of symptoms and adverse effects. Bottom line A lab value alone won’t “require” treatment — the usual cutoff is total testosterone <300 ng/dL, but clinicians treat only after confirming low levels and documenting symptoms, ruling out reversible causes, and discussing benefits/risks. Talk with your primary care doctor or an endocrinologist/urologist to get appropriate morning testing and individualized recommendations. If you want, I can: Help locate nearby Quest or Labcorp locations for morning testing, or Explain advantages/disadvantages of specific formulations (gel vs injection vs nasal) for your situation.

Mentioned in position 1 of 11

Read full answer with sources →
ChatGPTOct 15, 2026, 11:34 UTC
How much does BHRT cost per month and does insurance ever cover it?

Short answer Monthly out‑of‑pocket for BHRT usually runs from about $10–$600+ depending on what you use (generic estradiol pills at the low end, branded meds or pellets at the high end). Insurance will often cover FDA‑approved hormone products when medically necessary, but usually does not cover custom‑compounded BHRT or elective pellet programs without prior authorization. Details and typical price ranges (US, approximate) Generic estradiol tablets/creams/gels: $10–$60/month. (Often the cheapest option; commonly covered.) Estradiol patches (generic or brand names like Climara, Vivelle‑Dot): $30–$200/month depending on brand and insurance. Micronized progesterone (Prometrium — FDA‑approved): $30–$300/month depending on generic vs brand and dose. Branded combination products (e.g., Bijuva — oral estradiol + progesterone): can be several hundred dollars/month without insurance. Testosterone gels (for men or women): generics are cheaper ($30–$100+), branded gels (AndroGel, Testim) can be $200–600+/month without coverage. Compounded BHRT creams/gels/lozenges (custom pharmacy): typically $30–$200+ per month depending on dose and compound — usually paid out of pocket. Pellets (e.g., BioTE or other pellet therapies): insertion + pellets often $500–$2,000 every 3–6 months (works out to ~$100–$700/month), and these are frequently not covered by insurance. Why prices vary Product type (tablet vs patch vs pellet vs cream). FDA‑approved manufactured drugs are more likely to be on insurance formularies; compounded products usually are not. Dose and frequency. Local provider fees (pellet insertion, office visits, lab monitoring). Telemedicine or subscription services sometimes charge a monthly clinic fee on top of medication costs. Insurance coverage rules (general) Most insurers (including many Medicare Part D plans) will cover FDA‑approved hormone therapies when prescribed for a medical indication (e.g., menopausal symptoms, documented hormone deficiency, or gender‑affirming care). Coverage depends on your plan’s formulary, prior‑authorization rules, and whether a generic is available. Compounded BHRT (custom creams/lozenges made by compounding pharmacies) is commonly excluded from coverage. Pellet therapy is often considered elective and may be denied or only partially covered. For transgender/gender‑affirming hormones, many plans now cover therapy—policies vary; prior authorization is sometimes required. Specific brands/services to consider Climara / Vivelle‑Dot (estradiol patches) — FDA‑approved, widely used, more likely to be covered by insurance. Prometrium (micronized progesterone) — an FDA‑approved “natural” progesterone option often covered if indicated. Bijuva (combination estradiol + progesterone capsule) — FDA‑approved combination of bioidentical hormones; useful if you want a single FDA product rather than compounded therapy (higher brand cost). BioTE (pellet therapy) — well‑known pellet provider; convenient but often out‑of‑pocket and can be costly. Compounding pharmacies (Wedgewood, Empower, Belmar, etc.) — can tailor doses and formulations if you need a custom mix, but expect to pay cash. Money‑saving tips Ask the prescriber for a generic version or an FDA‑approved alternative if you want coverage. Use GoodRx or pharmacy discount cards for cash pricing on generics/brands. Ask your clinic for an itemized estimate (medication + procedure + labs). Check for manufacturer savings cards for brand products (e.g., some branded HRT drugs have discount programs). If choosing telehealth BHRT services (Plume, Gennev for menopause, Plume/Folx for trans care), compare their subscription fees and whether they dispense meds or send prescriptions to your local pharmacy. What you can do next Decide which route you’re considering (FDA‑approved pill/patch, compounded cream, pellet, or testosterone). Ask your provider for a specific medication name/dose and an estimated monthly cost. Call your insurer’s pharmacy/customer service with that drug name and NDC or formulary code to confirm coverage and whether prior authorization is needed. If you want, tell me which product type or your insurance plan and I can help estimate costs or draft questions to ask your insurer. If you tell me whether this is for menopause, gender‑affirming care, or low‑T for a man, and whether you prefer pellets vs pills/patches, I can give a tighter cost estimate and suggest the best insurance‑friendly options.

Mentioned in position 5 of 14

Read full answer with sources →
ChatGPTOct 15, 2026, 11:34 UTC
BHRT pellets vs creams vs patches: which is best and who offers them?

Short answer: there’s no one “best” BHRT delivery method — pellets, creams, and patches each have pros and cons. The right choice depends on which hormones you need, how steady you want levels to be, tolerance for procedures, safety profile, and how closely you want to be monitored. Below is a concise comparison and a list of commonly used brand/clinic options. 1) Pellets How they work: Small subcutaneous pellets (estradiol and/or testosterone) are implanted under the skin every 3–6 months to give steady hormone release. Pros: Very steady levels; low daily maintenance; good for people who dislike daily dosing. Cons: Minor surgical procedure for insertion/removal; dose adjustment requires re-implantation at the next interval; infection/bleeding risk; dosing is less flexible. Who offers them: BioTE Medical (popular pellet system and provider network), SottoPelle (European-style pellet therapy), many private hormone clinics and anti-aging/functional medicine practices that work with compounding pharmacies. Compounding pharmacies that supply pellets include Wedgewood Pharmacy and some local compounding pharmacies. 2) Topical creams/gels How they work: Compounded or commercial creams/gels applied to skin; transdermal absorption of estradiol, progesterone, or testosterone (absorption varies). Pros: Flexible dosing; noninvasive; easy to stop or change dose. Cons: Absorption is highly variable between people and body sites; risk of transfer to partners/children by skin contact; many creams are compounded (not FDA-reviewed), so potency/consistency can vary. Who offers them: Most compounding pharmacies (Empower Pharmacy, Wedgewood, Belmar and many local compounding pharmacies) produce BHRT creams. Clinics that commonly prescribe topical BHRT include BodyLogicMD, Defy Medical, and many integrative/anti-aging practices. Note: some products (topical testosterone gels like AndroGel, Testim) are FDA-approved for men, but many BHRT creams are compounded. 3) Patches How they work: Adhesive transdermal patches deliver estradiol (and in some cases testosterone) through the skin with relatively steady blood levels. Pros: Predictable, consistent delivery; easier dosing changes than pellets; FDA-approved patches exist for estradiol. Cons: Skin irritation; visible patch; daily/episodic replacement required; fewer progesterone patch options and limited FDA-approved testosterone patches (Androderm for men). Common FDA-approved brands: Vivelle-Dot (estradiol patch), Climara (estradiol patch), Alora (estradiol patch), Estraderm. For testosterone, Androderm is an approved transdermal patch for men (women’s use is off-label). Many clinics also prescribe compounded patches in some cases. Safety/regulation notes “Bioidentical” refers to chemical structure, but many compounded BHRT products are not FDA-approved and may have variable potency. Estradiol patches and some oral progesterone products (Prometrium, which is micronized progesterone) are FDA-approved. All forms of estrogen and testosterone carry potential risks (blood clots, stroke, breast cancer risk context-dependent, cardiovascular effects, etc.). Progesterone and dosing also affect risk. Safety depends on your age, medical history, and which hormones are used. Creams can transfer to partners/children. Pellets are a small surgical procedure. Patches can irritate skin. How to choose See a clinician experienced in hormone therapy (gynecologist, endocrinologist, or a reputable hormone clinic). They’ll base choice on symptoms, lab results, risk factors, lifestyle, and willingness for procedures. Prefer methods with good evidence for your situation; if you’re choosing compounded products, use a reputable compounding pharmacy and get follow-up labs. If you want the most predictable, adjustable FDA-regulated dosing: patches or FDA-approved topical formulations are a safer-first choice. Pellets are attractive for convenience and steady levels but are less adjustable and require a procedure. Who to contact / where to get them Pellet-focused: BioTE Medical providers, SottoPelle-trained clinicians (search each organization’s provider locator). Multi-method hormone clinics/telemedicine: BodyLogicMD, Defy Medical, Evernow (telehealth hormone care), and many local integrative medicine practices will prescribe patches, creams, or pellets depending on assessment. Compounding pharmacies (for creams/pellets when a compounded product is chosen): Wedgewood Pharmacy, Empower Pharmacy, Belmar Pharmacy and numerous accredited local compounding pharmacies (verify accreditation and reviews). For FDA-approved patch/gel products: see your regular prescriber (PCP, OB/GYN) who can prescribe brands like Vivelle-Dot, Climara, Androderm, AndroGel, Testim, or Prometrium where appropriate. If you want, I can: Help you compare two specific options (e.g., BioTE pellets vs Climara patch) for a specific hormone profile or condition. Find local clinicians or telemedicine providers that offer a given method in your area (tell me your city/zip).

Mentioned in position 8 of 16

Read full answer with sources →

TL;DR

AndroGel is a prescription testosterone replacement therapy gel made by AbbVie, applied topically to deliver controlled testosterone doses to men with hypogonadism. It is one of the most widely recognized brand-name TRT products in the United States. In WellRank's latest index it ranks eighth in TRT and men's health with 25% AI visibility, nineteenth in BHRT at 13%, and forty-first in menopause and women's health at 4%, appearing in 299 tracked AI mentions with the vast majority of those mentions carrying a neutral, clinical tone.

Company Overview

AndroGel is a branded pharmaceutical product owned and marketed by AbbVie, a publicly traded global biopharmaceutical company headquartered in North Chicago, Illinois. The product is distributed through licensed pharmacies and requires a physician prescription, operating within a traditional pharmaceutical sales and insurance reimbursement model. AbbVie promotes AndroGel directly to healthcare providers as well as through consumer advertising, which has made it one of the most recognized testosterone therapy brands in the country.

Product Features

  • Topical testosterone gel formulated for once-daily application
  • Available in 1% and 1.62% concentration strengths
  • Metered-dose pump and single-use packet delivery formats
  • FDA-approved specifically for male hypogonadism
  • Designed to restore testosterone to normal physiological range
  • Long-established clinical data and broad insurance formulary presence

Target Market

AndroGel is indicated for adult men diagnosed with hypogonadism, a condition in which the body does not produce sufficient testosterone. It is prescribed and dispensed throughout the United States through retail and specialty pharmacies. The product is not indicated for women or children, which explains its limited 4% visibility in menopause and women's health AI queries.

Buyer Personas

  • A middle-aged man recently diagnosed with low testosterone by his primary care physician or urologist who wants an FDA-approved, insurance-covered first-line treatment.
  • A men's health patient transitioning from injectable testosterone who prefers a non-injection daily routine.
  • An older male patient managing age-related hypogonadism under ongoing endocrinologist supervision.
  • A cost-conscious patient whose insurer covers brand-name AndroGel and who is researching out-of-pocket versus covered pricing before filling a prescription.

Funding & Performance

AndroGel is a product of AbbVie Inc., which is publicly traded on the NYSE under the ticker ABBV. Specific revenue figures attributable solely to AndroGel are not consistently broken out in recent AbbVie earnings disclosures and should be verified through current filings.

Recent Developments

AndroGel has faced increased generic competition following the expiration of key patents, and generic testosterone gel versions are now widely available, which has shifted some prescribing volume. AbbVie has continued to maintain the brand through direct-to-consumer awareness. The broader TRT market has grown notably with the rise of telehealth platforms offering competing testosterone therapies, a dynamic reflected in the co-mention of digital brands like Roman alongside AndroGel in AI answers.

Competitive Landscape

WellRank's co-mention data shows AndroGel is most frequently discussed alongside other TRT products including Testim, Androderm, Testopel, Depo-Testosterone, and Aveed, as well as telehealth-native brands like Roman. It also surfaces near women's hormone therapy brands such as Vivelle-Dot and Prometrium in broader BHRT conversations. Cost-comparison resources such as a breakdown of testosterone replacement therapy costs and Hims's guide to testosterone pricing frequently cite AndroGel as a benchmark brand when comparing TRT options.

AndroGel vs the brands AI recommends alongside it

The real competitive set in TRT and men's health: brands the engines name in the same answers, ranked on the latest day.

BrandRankAI visibility
AndroGel logo
AndroGelThis brand
#13
16.7%
Testim logo
Testim

263 shared answers

#14
16.7%
Androderm logo
Androderm

133 shared answers

#26
8.3%
Depo-Testosterone logo
Depo-Testosterone

113 shared answers

#12
16.7%
Roman logo
Roman

109 shared answers

#5
33.3%

Email me when overtakes AndroGel

One email the day the ranks flip. Nothing else.

User Sentiment

Of 299 AI mentions tracked by WellRank, 249 are neutral and clinical in tone, consistent with how AI engines treat an established FDA-approved pharmaceutical rather than a consumer wellness brand. Only 48 mentions are positive and just 2 are mixed or cautious, suggesting AndroGel faces little active criticism in AI-generated content. Community discussions such as this thread on real-world TRT costs reflect patient-level curiosity about cost and alternatives rather than negative sentiment toward the brand itself.

Pricing

Pricing for AndroGel varies significantly depending on insurance coverage, pharmacy, and whether a patient uses the branded product or an available generic. Out-of-pocket costs for brand-name AndroGel can be substantially higher than generics; resources like GoodRx's testosterone pricing page and Hone Health's TRT cost overview provide current discount and cash-pay estimates. AbbVie has historically offered a savings card program for eligible commercially insured patients, but specific figures are subject to change and should be confirmed directly.

Sources cited around AndroGel

The sites engines cite in answers mentioning this brand. Win these, win the answer.

Track AndroGel weekly

One email a week: rank moves, new competitors, and the answers that changed. No noise.

Work at AndroGel? Get your AI Visibility Audit.

See every buyer intent question your customers ask AI, which ones you are losing, who wins them instead, and the exact sources driving those answers. You will finally understand your buyer intent and what Propel would do to win it.